Wall Street Zen cut shares of Amdocs (NASDAQ:DOX – Free Report) from a buy rating to a hold rating in a report published on Saturday.
Other equities research analysts have also recently issued reports about the company. Barclays lowered their price objective on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Finally, Stifel Nicolaus lowered their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $92.33.
Get Our Latest Research Report on DOX
Amdocs Price Performance
Amdocs (NASDAQ:DOX – Get Free Report) last released its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the business posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Sell-side analysts forecast that Amdocs will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be paid a $0.569 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s payout ratio is 40.81%.
Institutional Investors Weigh In On Amdocs
Several hedge funds have recently added to or reduced their stakes in DOX. Pzena Investment Management LLC increased its position in shares of Amdocs by 82.6% during the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock valued at $969,100,000 after purchasing an additional 5,443,766 shares during the last quarter. LSV Asset Management lifted its position in Amdocs by 0.8% in the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock worth $296,159,000 after buying an additional 29,829 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Amdocs by 1.8% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after buying an additional 54,676 shares in the last quarter. Wellington Management Group LLP grew its position in Amdocs by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after acquiring an additional 91,900 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Amdocs by 0.3% during the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after acquiring an additional 9,207 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Recommended Stories
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
